Zobrazeno 1 - 10
of 69
pro vyhledávání: '"Peggy L.R. Harris"'
Autor:
Alankrita Raghavan, Folashade Otegbeye, Andrew E. Sloan, David C. Soler, Amber Kerstetter-Fogle, Peggy L.R. Harris
Publikováno v:
Neuro-Oncology. 23:vi101-vi102
INTRODUCTION Glioblastoma multiforme (GBM) is the most common primary central nervous system malignancy associated with a 12-15 month survival after surgery and radio-chemotherapy. Utilizing adoptive cellular immunotherapy using natural killer (NK) c
Autor:
Aryavarta M. S. Kumar, Andrew E Sloan, Serah Choi, M.Z. Kharouta, Robin Buerki, Anthony Sloan, David B. Mansur, Mitchell Machtay, Amber Kerstetter-Fogle, Theresa Elder, N. Damico, Peggy L.R. Harris, Aashish D. Bhatt
Publikováno v:
Neuro Oncol
BACKGROUND There are conflicting reports regarding the prognostic value of platelet and other blood counts in glioblastoma. However, few series have looked at all hematologic parameters simultaneously. METHODS We performed a retrospective chart revie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76aa393b9280e96c907ec15c6a110902
https://europepmc.org/articles/PMC7651432/
https://europepmc.org/articles/PMC7651432/
Autor:
Peggy L.R. Harris, John Willis, Alankrita Raghavan, Jeremy N. Rich, Anthony Sloan, Jill S. Barnholtz-Sloan, Amber Kerstetter-Fogle, Theresa A Elder, Eckhard Jankowsky, Gino Cioffi, Christine Lee-Poturalski, Andrew E Sloan
Publikováno v:
Neuro Oncol
Glioblastoma (GBM) is recognized as one of the deadliest forms of cancer, despite aggressive therapy consisting of maximal surgical resection followed by concurrent radiation and chemotherapy, the median survival remains ~12 months. Glioma stem cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91469728bdc8881ede525b55dcaf71f3
https://europepmc.org/articles/PMC7651465/
https://europepmc.org/articles/PMC7651465/
Autor:
Harry Hoffman, Anthony Sloan, Jill S. Barnholtz-Sloan, Theresa Elder, Amber Kerstetter-Fogle, Peggy L.R. Harris, Andrew E. Sloan, Marta Couce
Publikováno v:
Neuro Oncol
INTRODUCTION Glioblastomas (GBM) are the most common and malignant primary brain tumors. Their rapid growth and invasion into neuronal parenchyma is devastating, with limited treatment options. Genomic alterations have been extensively studied in gli
Autor:
Amber Kerstetter-Fogle, Eckhard Jankowsky, Andrew E. Sloan, Harry Hoffman, Anirban Sen Gupta, Ansh Desai, Jill S. Barnholtz-Sloan, Anthony Sloan, Jeremy N. Rich, Theresa Elder, Peggy L.R. Harris, Christine Lee-Poturalski, Gino Cioffi
Publikováno v:
Neuro-Oncology. 23:vi24-vi24
The effect of platelets on oncogenesis has been studied extensively in cancer metastasis, but not in glioblastoma (GBM), where metastasis is rare. Here we identify the unique crosstalk between glioma stem cells (GSCs) and platelets within GBM solid t
Autor:
Alankrita Raghavan, Ge Jin, Harry Hoffman, Andrew E. Sloan, Jill S. Barnholtz-Sloan, Peggy L.R. Harris, Amber Kerstetter-Fogle, Marta Couce, Anthony Sloan, Aaron Weinberg
Publikováno v:
Neuro-Oncology. 23:vi25-vi25
INTRODUCTION Glioblastoma (GBM) is the most common primary malignant brain tumor with a median overall survival of 12-15months. GBM aggressiveness and poor response to treatment are often attributed to a small population of stem-like cells referred t
Autor:
Eckhard Jankowsky, Michael A. Vogelbaum, John Willis, Andrew E Sloan, Amber Kerstetter-Fogle, Christine Lee-Poturalski, Jeremy N. Rich, Alankrita Raghavan, Peggy L.R. Harris
Publikováno v:
Neuro Oncol
Glioblastoma Multiforme (GBM) is the most common and lethal malignant primary adult brain tumor. Therapy resistance and tumor recurrence in GBM have been attributed to glioma stem cells (GSCs), which are found in hypoxic but perivascular niches. We h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4221c6f35293de344101be183e1e171
https://europepmc.org/articles/PMC6847874/
https://europepmc.org/articles/PMC6847874/
Autor:
Veronique Beiss, Peggy L.R. Harris, Sourabh Shukla, Amber Kerstetter-Fogle, Andrew E. Sloan, Chao Wang, Nicole F. Steinmetz
Publikováno v:
Cancers, Vol 11, Iss 4, p 515 (2019)
Cancers, vol 11, iss 4
Cancers
Volume 11
Issue 4
Cancers, vol 11, iss 4
Cancers
Volume 11
Issue 4
Despite aggressive multi-modality treatment with surgery, radiation and chemotherapies, malignant glioma inevitably recurs and has dismal survival rates. Recent progress in immunotherapy has led to a resurgence of interest, and immunotherapies are be
Autor:
Sourabh Shukla, Andrew E Sloan, Amber Kerstetter-Fogle, Nicole F. Steinmetz, Veronique Beiss, Peggy L.R. Harris
Publikováno v:
Neuro-Oncology. 20:vi138-vi138
Glioblastoma multiforme is the most malignant brain cancer affecting adults. Despite recent advancements, the current prognosis is dismal with median survival of 12 months post diagnosis even with multi-modal therapy. Cancer immunotherapy has made si
Autor:
Peter Oettgen, Summer L. Nugent, A. L. Morrison, Mark A. Smith, Hari Shanker Sharma, Hyoung Gon Lee, Xiongwei Zhu, George Perry, Vladan Bajic, Rudy J. Castellani, Peggy L.R. Harris, Shu G. Chen
Publikováno v:
Journal of Neural Transmission. 118:23-26
CD3ζ is a subunit of the CD3 molecule that, until recently, appeared restricted to T-cells and natural killer cells. However, experimental studies have demonstrated a role of CD3ζ in dendritic outgrowth in the visual system as well as in synaptic p